autologous NK cell therapy
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for autologous NK cell therapy, covering 2017-04-25 to 2026-01-29. Get the full timeline:
Most recent: Clinical Trial Update: Chemoimmunotherapy Combined With Autologous NK Cell Therapy for Pediatric Patients With Refractory and Relapsed High-Risk Neuroblastoma and Ganglioneuroblastoma [Phase 3]